Skip to content

The establishment and application of ultrasonic integrated evaluation system in the prevention and treatment of acute kidney injury

The establishment and application of ultrasonic integrated evaluation system in the prevention and treatment of acute kidney injury

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DOD-15005831
Enrollment
Unknown
Registered
2015-01-15
Start date
2015-01-30
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute kidney injury

Interventions

Gold Standard:
Index test:

Sponsors

Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Subjects must satisfy the following criteria to be enrolled in the study: 1. Clinical diagnosis of acute or chronic kidney injury; 2. Male or female, aged 18-80 years old; 3. signed informed consent; 4.Patients can breathe in, breathe out and hold their breathe with ease, communication without difficulty.

Exclusion criteria

Exclusion criteria: Potential subjects who meet any of the following criteria will be excluded from participating in the study: 1. Refuse to sign informed consent; 2. allergy to micro bubble hexafluoride drug; 3. Patients with cardiopulmonary insufficiency, pleural effusion, pulmonary infections; 4. Patients with asthma, chronic bronchitis; 5. Patients with pregnancy; 6. Patients can't cooperate or have a difficulty in breathing in, breathing out or holding their breathe; 7. Patients beening diagnosed with End-stage kidney disease.

Design outcomes

Primary

MeasureTime frame
Renal ultrasound;Urine routine test;Kidney function;KIM-1;NGAL;L-FABP;Cystatin C;

Countries

China

Contacts

Public ContactShan Mou
shan_mou@126.com+86 13918221242

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026